ENTITY

Dogwood Therapeutics (DWTX US)

11
Analysis
Health Care • United States
Dogwood Therapeutics, Inc. operates as a development-stage biotechnology. The Company develops novel therapeutics and sodium channel blocker to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain indications. Dogwood Therapeutics serves patients in the United States.
more
Company Presentation • 29 Sep 2025 20:30
Company Presentation • 08 Aug 2025 06:00
Company Presentation • 07 Oct 2024 20:30
Company Presentation • 07 Oct 2024 20:30
No more presentations
x